Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High Content & Phenotypic Screening 2016

Darren Cawkill's Biography

Darren Cawkill, Associate Director, Pfizer

Dr Darren Cawkill has been at Neusentis (Pfizer’s Pain & Sensory Disorders research unit) in Cambridge
UK for 4 years and with Pfizer for a total of 16 years. On completing his PhD in 1998, he joined Pfizer from the University of Leeds and has since worked in the fields of protein biochemistry, cell line generation, cell biology and in vitro pharmacology. His current role is leading the plate-based assay development and screening group at Neusentis. As an R&D hub, Neusentis focuses on new treatments for pain & sensory disorders and places a strong emphasis on the application of new scientific research and technologies to improve the biological relevance of assays used in this area of drug discovery.

Darren Cawkill Image

Phenotypic Screening with iPSC-Sensory Neuron Excitability Assays

Tuesday, 10 May 2016 at 11:45

Add to Calendar ▼2016-05-10 11:45:002016-05-10 12:45:00Europe/LondonPhenotypic Screening with iPSC-Sensory Neuron Excitability AssaysHigh Content and Phenotypic Screening 2016 in Cambridge, UKCambridge,

This presentation will provide an overview of phenotypic assay development and validation using both ‘normal’ and patient-derived hiPSC-sensory neurons; together with a summary of ongoing chemogenomics screening initiatives aimed at new target identification for hyperexcitability disorders.

Add to Calendar ▼2016-05-10 00:00:002016-05-11 00:00:00Europe/LondonHigh Content and Phenotypic Screening 2016High Content and Phenotypic Screening 2016 in Cambridge, UKCambridge,